GW&K INVESTMENT MANAGEMENT, LLC – Halozyme Therapeutics, Inc. Transaction History
GW&K INVESTMENT MANAGEMENT, LLC portfolio value:
$87.10M
portfolio value
GW&K INVESTMENT MANAGEMENT, LLC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +34.05% | 559.65K shares | 14.79M | $39.54 | 2.20M |
| Q2 2022 | share | Decrease | -0.63% | -10.47K shares | 6.35M | $44 | 1.64M |
| Q1 2022 | share | Increase | +6.11% | 95.21K shares | 3.28M | $39.88 | 1.65M |
| Q4 2021 | share | Increase | +3.99% | 59.87K shares | 1.70M | $40.32 | 1.55M |
| Q3 2021 | share | Increase | +40.97% | 435.57K shares | 12.69M | $40.68 | 1.49M |
| Q2 2021 | share | Increase | +0.19% | 1.96K shares | 4.03M | $45.41 | 1.06M |
| Q1 2021 | share | Increase | +26.00% | 218.97K shares | 8.27M | $41.69 | 1.06M |
| Q4 2020 | share | Increase | 0.00% | 842.25K shares | 35.97M | $42.71 | 842.25K |